연구성과로 돌아가기
JCR 2024 저널 목록 (1570 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annee du Maghreb | CNRS EDITIONS | 2109-9405 | 2109-9405 | ESCI | AREA STUDIES | 37 | 0.2 | Q4 | 80.5 | 19.5 | 147/182 | 0.1 | Q4 | 0.2 | 0.1 | 0.11 | 165/182 | Q4 | 9.62 | 0.000 | 0.024 | 0.095 | Q4 | 36 | 100.0% | N/A | 12.1 | 36 | 86.6% | 2025-08-05 16:02:29 | 바로가기 |
| Asia-Pacific Journal of Clinical Oncology | WILEY | 1743-7555 | 1743-7563 | SCIE | ONCOLOGY | 2,016 | 1.6 | Q4 | 80.5 | 19.5 | 263/326 | 1.6 | Q4 | 1.6 | 0.3 | 0.31 | 273/326 | Q4 | 16.41 | 0.002 | 0.475 | 0.449 | Q4 | 69 | 84.1% | 6.1 | 5.9 | 58 | 23.8% | 2025-08-05 16:04:25 | 바로가기 |
| Asia-Pacific Journal-Japan Focus | JAPAN FOCUS | 1557-4660 | 1557-4660 | ESCI | AREA STUDIES | 394 | 0.2 | Q4 | 80.5 | 19.5 | 147/182 | 0.3 | Q4 | 0.2 | 0.1 | 0.25 | 150/182 | Q4 | 17.86 | 0.000 | 0.094 | 0.129 | Q4 | 50 | 100.0% | 8.9 | 10.2 | 50 | 0.6% | 2025-08-05 16:02:29 | 바로가기 |
| Australasian Review of African Studies | AFRICAN STUDIES ASSOC AUSTRALASIA & PACIFIC | 1447-8420 | 2203-5184 | ESCI | AREA STUDIES | 82 | 0.2 | Q4 | 80.5 | 19.5 | 147/182 | 0.3 | Q4 | 0.2 | N/A | 0.12 | 163/182 | Q4 | 10.71 | 0.000 | 0.007 | 0.088 | Q4 | 0 | N/A | N/A | N/A | 0 | 0.0% | 2025-08-05 16:02:29 | 바로가기 |
| Austrian Journal of Statistics | AUSTRIAN STATISTICAL SOC | 1026-597X | 1026-597X | ESCI | STATISTICS & PROBABILITY | 293 | 0.7 | Q4 | 80.5 | 19.5 | 135/167 | 0.7 | Q4 | 0.7 | 0.1 | 0.42 | 115/167 | Q3 | 31.44 | 0.000 | N/A | N/A | N/A | 32 | 100.0% | 6.8 | 10.8 | 32 | 99.0% | 2025-08-05 16:05:20 | 바로가기 |
| Bandung | BRILL | 2590-0013 | 2198-3534 | ESCI | AREA STUDIES | 57 | 0.2 | Q4 | 80.5 | 19.5 | 147/182 | N/A | N/A | 0.2 | <0.1 | 0.23 | 154/182 | Q4 | 15.66 | 0.000 | 0.013 | N/A | N/A | 18 | 94.4% | N/A | 9.9 | 17 | 37.5% | 2025-08-05 16:02:29 | 바로가기 |
| CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | CANADIAN SCIENCE PUBLISHING | 0008-4212 | 1205-7541 | SCIE | PHARMACOLOGY & PHARMACY | 4,451 | 1.3 | Q4 | 80.5 | 19.5 | 284/352 | 1.7 | Q4 | 1.3 | 0.3 | 0.56 | 208/353 | Q3 | 41.22 | 0.002 | 0.355 | 0.337 | Q4 | 66 | 68.2% | 10.8 | 9.1 | 45 | 11.0% | 2025-08-05 16:04:34 | 바로가기 |
| CHEMICAL & PHARMACEUTICAL BULLETIN | PHARMACEUTICAL SOC JAPAN | 0009-2363 | N/A | SCIE | PHARMACOLOGY & PHARMACY | 11,090 | 1.3 | Q4 | 80.5 | 19.5 | 284/352 | 1.6 | Q4 | 1.2 | 0.4 | 0.33 | 289/353 | Q4 | 18.27 | 0.002 | 0.423 | 0.317 | Q4 | 156 | 91.0% | 21.3 | 9.7 | 142 | 97.4% | 2025-08-05 16:04:33 | 바로가기 |
| China and Asia | BRILL | 2589-4641 | 2589-465X | ESCI | AREA STUDIES | 7 | 0.2 | Q4 | 80.5 | 19.5 | 147/182 | 0.1 | Q4 | 0.2 | 0.1 | 0.46 | 120/182 | Q3 | 34.34 | 0.000 | 0.007 | 0.097 | Q4 | 8 | 100.0% | N/A | 25.4 | 8 | 0.0% | 2025-08-05 16:02:29 | 바로가기 |
| Cuadernos Inter c a mbio sobre Centroamerica y el Caribe | UNIV COSTA RICA, CENTRO INVESTIGACION & IDENTIDAD & CULTURA LATINOAMERICANA | 1659-0139 | 1659-4940 | ESCI | AREA STUDIES | 49 | 0.2 | Q4 | 80.5 | 19.5 | 147/182 | 0.2 | Q4 | 0.2 | 0.1 | 0.05 | 171/182 | Q4 | 6.32 | 0.000 | 0.026 | 0.131 | Q4 | 17 | 100.0% | N/A | 7.0 | 17 | 83.3% | 2025-08-05 16:02:29 | 바로가기 |
| ESAIM-Probability and Statistics | EDP SCIENCES S A | 1292-8100 | 1262-3318 | SCIE | STATISTICS & PROBABILITY | 392 | 0.7 | Q4 | 80.5 | 19.5 | 135/167 | 0.6 | Q4 | 0.7 | 0.1 | 0.41 | 119/167 | Q3 | 29.04 | 0.001 | 0.120 | 0.486 | Q3 | 17 | 100.0% | 11.1 | 16.0 | 17 | 93.3% | 2025-08-05 16:05:20 | 바로가기 |
| European Journal of East Asian Studies | BRILL | 1568-0584 | 1570-0615 | ESCI | AREA STUDIES | 119 | 0.2 | Q4 | 80.5 | 19.5 | 147/182 | N/A | N/A | 0.2 | <0.1 | 0.34 | 139/182 | Q4 | 23.90 | 0.000 | 0.025 | N/A | N/A | 13 | 100.0% | 12.3 | 11.4 | 13 | 5.4% | 2025-08-05 16:02:29 | 바로가기 |
| FARMACIA | SOC STIINTE FARMACEUTICE ROMANIA | 0014-8237 | 2065-0019 | SCIE | PHARMACOLOGY & PHARMACY | 1,342 | 1.3 | Q4 | 80.5 | 19.5 | 284/352 | 1.0 | Q4 | 0.6 | 0.2 | 0.37 | 277/353 | Q4 | 21.67 | 0.001 | 0.123 | 0.093 | Q4 | 158 | 90.5% | 5.2 | 6.4 | 143 | 97.6% | 2025-08-05 16:04:35 | 바로가기 |
| FARMACIA HOSPITALARIA | ELSEVIER SCIENCE INC | 1130-6343 | 2171-8695 | ESCI | PHARMACOLOGY & PHARMACY | 566 | 1.3 | Q4 | 80.5 | 19.5 | 284/352 | 1.3 | Q4 | 1.1 | 0.3 | 0.27 | 301/353 | Q4 | 14.87 | 0.000 | 0.106 | 0.257 | Q4 | 89 | 89.9% | 4.9 | 5.9 | 80 | 68.2% | 2025-08-05 16:04:35 | 바로가기 |
| Hematology Transfusion and Cell Therapy | ELSEVIER | 2531-1379 | 2531-1379 | ESCI | ONCOLOGY | 776 | 1.6 | Q4 | 80.5 | 19.5 | 263/326 | 1.7 | Q4 | 1.6 | 0.4 | 0.36 | 256/326 | Q4 | 21.63 | 0.001 | 0.271 | 0.414 | Q4 | 177 | 91.0% | 3.2 | 8.7 | 161 | 99.4% | 2025-08-05 16:04:25 | 바로가기 |
페이지 이동: